- Home
- LVS vs A Comparison
LVS vs A Comparison
Compare LVS & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVS
- A
- Stock Information
- Founded
- LVS 1988
- A 1999
- Country
- LVS United States
- A United States
- Employees
- LVS N/A
- A N/A
- Industry
- LVS Hotels/Resorts
- A Biotechnology: Laboratory Analytical Instruments
- Sector
- LVS Consumer Discretionary
- A Industrials
- Exchange
- LVS Nasdaq
- A Nasdaq
- Market Cap
- LVS 32.3B
- A 38.6B
- IPO Year
- LVS 2004
- A 1999
- Fundamental
- Price
- LVS $44.03
- A $135.35
- Analyst Decision
- LVS Buy
- A Buy
- Analyst Count
- LVS 14
- A 15
- Target Price
- LVS $59.54
- A $142.64
- AVG Volume (30 Days)
- LVS 6.8M
- A 1.6M
- Earning Date
- LVS 04-16-2025
- A 02-26-2025
- Dividend Yield
- LVS 2.27%
- A 0.73%
- EPS Growth
- LVS 22.50
- A 5.73
- EPS
- LVS 1.96
- A 4.43
- Revenue
- LVS $11,298,000,000.00
- A $6,510,000,000.00
- Revenue This Year
- LVS $9.91
- A $7.05
- Revenue Next Year
- LVS $5.62
- A $6.43
- P/E Ratio
- LVS $22.46
- A $30.56
- Revenue Growth
- LVS 8.93
- A N/A
- 52 Week Low
- LVS $36.62
- A $124.16
- 52 Week High
- LVS $56.61
- A $155.35
- Technical
- Relative Strength Index (RSI)
- LVS 47.36
- A 35.14
- Support Level
- LVS $41.15
- A $133.94
- Resistance Level
- LVS $44.36
- A $138.58
- Average True Range (ATR)
- LVS 1.18
- A 2.90
- MACD
- LVS 0.42
- A -1.44
- Stochastic Oscillator
- LVS 62.77
- A 8.61
About LVS Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore toward the end of 2028. Its Venetian and Palazzo Las Vegas assets in the U.S. were sold to Apollo and VICI in 2022. With the sale of its Vegas assets, the company generates all its EBITDA from Asia, with its casino operations generating the majority of sales.
About A Agilent Technologies Inc.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.